Prominent Nontuberculous Mycobacterial (NTM) Infections emerging therapies include ALIS, Antimycobacterial regimen, ...
Abstract: This research study systematically examines the application of deep learning techniques in predicting lung infections including cancer, pneumonia, tuberculosis, Covid 19 and so on. The ...
A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...
MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...
The rise of infections caused by Mgen, C. auris, treatment-resistant E. coli, and more could become future public-health threats, experts say.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback